Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial Intelligence

Award Number: K25HL157601
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 12/01/2023
PERIOD OF PERFORMANCE END DATE: 11/30/2028

Group Awards By:

View Award Description

Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial Intelligence - Project Summary Pulmonary hypertension (PH) is a heterogeneous condition that occurs most frequently as complicating comorbidity of very common disease in the western world, including COPD, heart failure, and blood clots in the lung. In patients with PH secondary to COPD (Group III) mortality risk is about twice as high than in patients with COPD and normal pulmonary artery pressure. Medications developed successfully for Group I disease have not shown much utility in Group III PH. Additionally, non-invasive screening and early detection remain challenging. For this reason, etiology and evolution of PH are still poorly understood and the response to potential interventions is very difficult to measure. In recent years, radiologists have been making observation of the loss of distal vasculature (pruning), increased vascular “tortuosity”, and proximal vascular dilation in patients with PH. In this career development proposal, we hypothesize that the great power and recent advances in artificial intelligence can be leveraged to identify new functional and structural markers that define the presence of PH in smokers from non-contrast CT images. These CT-based features will significantly improve our ability to define the main structural and functional effects of PH in COPD patients and assess pathological conditions, leading to a better understanding of the genetic and biological underpinnings of the disease. Aim 1 of this application involves refining our algorithm for vascular morphology assessment and applying it to investigate how the pulmonary vasculature is affected in presence of PH Group III. Five markers of presence of disease will be explored. The goal of Aim 2 is to develop an innovative approach to assess the level of pulmonary perfusion from non-contrast non cardiac gated CT images and to apply it to explore new functional markers of disease. Both in Aims 1 and 2 association with biological outcomes will be performed. Finally, in Aim 3 we will validate the biological relevance of the endpoints determined in Aims 1 and 2 by performing common and rare variant association studies. Preliminary data obtained with our published methods show promising results. We show that using artificial intelligence we can effectively segment pulmonary vessels, separate arteries and veins, and measure small vessels with an accuracy which outperforms state-of-the-art methods. Additionally, we developed an innovative technique that synthesized perfusion maps from non-contrast CT to assess perfusion defects in PH patients. Together, the research proposed in the aims of this award will take full advantage of the comprehensive dataset available through the COPDGene study. The execution of the aims in this proposal will be possible through active collaboration with Dr. Raul San Jose Estepar, Ph.D. as the mentor and an outstanding Advisory Committee including renowned leaders in the fields of medical image analysis, translational research, quantitative imaging in pulmonary vascular disease, and the genetic epidemiology of COPD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $189,000 )
2026	2026	BRIGHAM & WOMENS HOSPITAL INC	75 FRANCIS ST	BOSTON	MA	02115	SUFFOLK	USA	Lung Diseases Research	000	3	2/12/2026	NON-COMPETING CONTINUATION	$189,000
														Subtotal = $189,000

Issue Date FY: 2025 ( Subtotal = $187,320 )
2025	2025	BRIGHAM & WOMENS HOSPITAL INC	75 FRANCIS ST	BOSTON	MA	02115	SUFFOLK	USA	Lung Diseases Research	000	2	11/27/2024	NON-COMPETING CONTINUATION	$187,320
														Subtotal = $187,320

Issue Date FY: 2024 ( Subtotal = $186,840 )
2024	2024	BRIGHAM & WOMENS HOSPITAL INC	75 FRANCIS ST	BOSTON	MA	02115	SUFFOLK	USA	Lung Diseases Research	000	1	12/1/2023	NEW	$186,840
														Subtotal = $186,840

Grand Total All Awards = $563,160

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial Intelligence

Award Number: K25HL157601

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 12/01/2023

PERIOD OF PERFORMANCE END DATE: 11/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer